Wockhardt is currently trading at Rs. 460.55, up by 18.10 points or 4.09% from its previous closing of Rs. 442.45 on the BSE.
The scrip opened at Rs. 448.00 and has touched a high and low of Rs. 478.00 and Rs. 448.00 respectively. So far 379192 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 478.00 on 14-Feb-2012 and a 52 week low of Rs. 251.25 on 06-Jan-2012.
Last one week high and low of the scrip stood at Rs. 478.00 and Rs. 417.80 respectively. The current market cap of the company is Rs. 5056.49 crore.
The promoters holding in the company stood at 73.64% while Institutions and Non-Institutions held 7.44% and 18.53% respectively.
Drug firm, Wockhardt’s consolidated net profit rose by 50.21% to Rs 212.81 crore in the third quarter ended December 31, 2011, on the back of strong sales in the US market. The company had posted a net profit of Rs 141.67 crore for the corresponding period last fiscal.
Net sales of the company rose by 27.12% to Rs 1,208.67 crore in the quarter ended December 31, 2011, from Rs 950.80 crore in the same period last fiscal.
On a standalone basis, the company posted a net profit of Rs 116.16 crore for the third quarter, as against Rs 66.66 crore for the same period last financial year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |